Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability

dc.contributor.authorFernández de las Peñas, César
dc.contributor.authorPalacios Ceña, Domingo
dc.contributor.authorGómez Mayordomo, Víctor
dc.contributor.authorPalacios Ceña, María
dc.contributor.authorRodríguez Jiménez, Jorge
dc.contributor.authorde la Llave Rincón, Ana I.
dc.contributor.authorVelasco Arribas, María
dc.contributor.authorFuensalida Novo, Stella
dc.contributor.authorAmbite Quesada, Silvia
dc.contributor.authorGuijarro, Carlos
dc.contributor.authorCuadrado, María L.
dc.contributor.authorFlorencio, Lidiane L.
dc.contributor.authorArias Navalón, José Antonio
dc.contributor.authorOrtega Santiago, Ricardo
dc.contributor.authorElvira Martínez, Carlos M.
dc.contributor.authorMolina Trigueros, Luis J.
dc.contributor.authorTorres Macho, Juan
dc.contributor.authorSebastián Viana, Tomas
dc.contributor.authorCanto Diez, María Gabriela
dc.contributor.authorCigarán Méndez, Margarita
dc.contributor.authorHernández Barrera, Valentín
dc.contributor.authorArendt Nielsen, Lars
dc.date.accessioned2021-10-13T13:44:25Z
dc.date.available2021-10-13T13:44:25Z
dc.date.created2021-09-21
dc.description.abstractBackground: Multicentre studies focussing on specific longterm post-COVID-19 symptoms are scarce. Objective: The aim of this study was to determine the levels of fatigue and dyspnoea, repercussions on daily life activities, and risk factors associated with fatigue or dyspnoea in COVID-19 survivors at long term after hospital discharge. Methods: Age, gender, height, weight, symptoms at hospitalization, preexisting medical comorbidity, intensive care unit admission, and the presence of cardio-respiratory symptoms developed after severe acute respiratory syndrome coronavirus 2 infection were collected from patients who recovered from COVID-19 at 4 hospitals in Madrid (Spain) from March 1 to May 31, 2020 (first COVID-19 wave). The Functional Impairment Checklist was used for evaluating fatigue/dyspnoea levels and functional limitations. Results: A total of 1,142 patients (48% women, age: 61, standard deviation [SD]: 17 years) were assessed 7.0 months (SD 0.6) after hospitalization. Fatigue was present in 61% patients, dyspnoea with activity in 55%, and dyspnoea at rest in 23.5%. Only 355 (31.1%) patients did not exhibit fatigue and/or dyspnoea 7 months after hospitalization. Forty-five per cent reported functional limitations with daily living activities. Risk factors associated with fatigue and dyspnoea included female gender, number of pre-existing comorbidities, and number of symptoms at hospitalization. The number of days at hospital was a risk factor just for dyspnoea. Conclusions: Fatigue and/or dyspnoea were present in 70% of hospitalized COVID-19 survivors 7 months after discharge. In addition, 45% patients exhibited limitations on daily living activities. Being female, higher number of pre-existing medical comorbidities and number of symptoms at hospitalization were risk factors associated to fatigue/dyspnoea in COVID-19 survivors 7 months after hospitalization.es_ES
dc.formatapplication/pdfes_ES
dc.identifier.locationN/Aes_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12080/25921
dc.languageenges_ES
dc.rightsCC-BYes_ES
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.eses_ES
dc.subjectCOVID-19 · Fatigue · Dyspnoea · Function · Risk factorses_ES
dc.titleFatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disabilityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES

Files

Collections